| Basics |
Cerus Corporation
Cerus Corp is a biomedical products company. It is engaged in developing and commercializing the INTERCEPT Blood System to enhance blood safety.
|
| IPO Date: |
January 31, 1997 |
| Sector: |
Healthcare |
| Industry: |
Health Care Equipment and Supplies |
| Market Cap: |
$246.6M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.12 | 2.74%
|
| Avg Daily Range (30 D): |
$0.05 | 3.32%
|
| Avg Daily Range (90 D): |
$0.05 | 3.24%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.74M |
| Avg Daily Volume (30 D): |
1.23M |
| Avg Daily Volume (90 D): |
1.28M |
| Trade Size |
| Avg Trade Size (Sh.): |
178 |
| Avg Trade Size (Sh.) (30 D): |
213 |
| Avg Trade Size (Sh.) (90 D): |
213 |
| Institutional Trades |
| Total Inst.Trades: |
941 |
| Avg Inst. Trade: |
$1.28M |
| Avg Inst. Trade (30 D): |
$1.09M |
| Avg Inst. Trade (90 D): |
$1.13M |
| Avg Inst. Trade Volume: |
.24M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$1.27M |
| Avg Closing Trade (30 D): |
$.93M |
| Avg Closing Trade (90 D): |
$1.08M |
| Avg Closing Volume: |
225.79K |
|
|
|
|
| Financials |
| |
TTM |
Q4 2024 |
FY 2024 |
|
Basic EPS
|
$-.11
|
$-.01
|
$-.11
|
|
Diluted EPS
|
$-.11
|
$-.01
|
$-.11
|
|
Revenue
|
$ 201.32M
|
$ 114.08M
|
$ 201.32M
|
|
Gross Profit
|
$
|
$
|
$
|
|
Net Income / Loss
|
$ -20.96M
|
$ -2.56M
|
$ -20.96M
|
|
Operating Income / Loss
|
$ -14.23M
|
$ -1.45M
|
$ -14.23M
|
|
Cost of Revenue
|
$
|
$
|
$
|
|
Net Cash Flow
|
$ 8M
|
$ -1.85M
|
$ 8M
|
|
PE Ratio
|
|
|
|
|
